BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zorkina Y, Abramova O, Ushakova V, Morozova A, Zubkov E, Valikhov M, Melnikov P, Majouga A, Chekhonin V. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 2020;25:E5294. [PMID: 33202839 DOI: 10.3390/molecules25225294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Tavanti F, Pedone A, Menziani MC. Disclosing the Interaction of Gold Nanoparticles with Aβ(1-40) Monomers through Replica Exchange Molecular Dynamics Simulations. Int J Mol Sci 2020;22:E26. [PMID: 33375086 DOI: 10.3390/ijms22010026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jo S, Kim HS, Won M, Champanhac C, Kim JS, Wurm FR, Landfester K. Dual‐Targeted Nanoreactors and Prodrugs: Hydrogen Peroxide Triggers Oxidative Damage and Prodrug Activation for Synergistic Elimination of Cancer Cells. Adv Funct Materials. [DOI: 10.1002/adfm.202200791] [Reference Citation Analysis]
3 Huang Y, Chang Y, Liu L, Wang J. Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides. Molecules 2021;26:4301. [PMID: 34299575 DOI: 10.3390/molecules26144301] [Reference Citation Analysis]
4 Pensado-López A, Fernández-Rey J, Reimunde P, Crecente-Campo J, Sánchez L, Torres Andón F. Zebrafish Models for the Safety and Therapeutic Testing of Nanoparticles with a Focus on Macrophages. Nanomaterials (Basel) 2021;11:1784. [PMID: 34361170 DOI: 10.3390/nano11071784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bergonzi MC, Bilia AR, Landucci E. Applications of innovative technologies to the delivery of antipsychotics. Drug Discov Today 2021:S1359-6446(21)00426-8. [PMID: 34601123 DOI: 10.1016/j.drudis.2021.09.019] [Reference Citation Analysis]
6 Patel RB, Rao HR, Thakkar DV, Patel MR. Comprehending the potential of metallic, lipid, and polymer-based nanocarriers for treatment and management of depression. Neurochem Int 2021;153:105259. [PMID: 34942308 DOI: 10.1016/j.neuint.2021.105259] [Reference Citation Analysis]
7 Wijaya CJ, Ismadji S, Gunawan S. A Review of Lignocellulosic-Derived Nanoparticles for Drug Delivery Applications: Lignin Nanoparticles, Xylan Nanoparticles, and Cellulose Nanocrystals. Molecules 2021;26:676. [PMID: 33525445 DOI: 10.3390/molecules26030676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Verdini F, Gaudino EC, Canova E, Tabasso S, Behbahani PJ, Cravotto G. Lignin as a Natural Carrier for the Efficient Delivery of Bioactive Compounds: From Waste to Health. Molecules 2022;27:3598. [PMID: 35684534 DOI: 10.3390/molecules27113598] [Reference Citation Analysis]